Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5646-5652

  Wilmer, W A ^a   Kaumaya, P T ^b   Ember, J A ^c   Cosio, F G ^a,b  

^a Division of Nephrology   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A [DEARGININE]; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; MESANGIUM CELL; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; CELLS, CULTURED; COMPLEMENT C5A; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENES, FOS; GENES, JUN; GLOMERULAR MESANGIUM; HUMANS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0032103095     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hugli, T. E. 1984. Structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 7:193.
2. Hebert, L. A., F. G. Cosio, and D. J. Birmingham. 1996. Complement and complement regulatory proteins in renal diseases. In Immunologic Renal Diseases. E. G. Nielson and W. G. Couser, eds. Lippincott-Raven, Philadelphia, p. 377.
3. Okusawa, S., K. B. Yancey, J. W. M. van der Meer, S. Endres, G. Lonnemann, K. Hefter, M. M. Frank, J. F. Burke, C. A. Dinarello, and J. A. Gelfand. 1988. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: comparison with secretion of interleukin 1βand imerleukin 1α. J. Exp. Med. 168:443.
4. Morgan, E. L., S. Sanderson, W. Scholz, D. J. Noonan, W. O. Weigle, and T. E. Hugli. 1992. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148:3937.
5. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147.
6. Mulligan, M. S., E. Schmid, G. O. Till, T. E. Hugli, H. P. Friedl, R. A. Roth, and P. A. Ward. 1997. C5a-dependent up-regulation in vivo of lung vascular P-selectin. J. Immunol. 158:1857.
7. Gerard, N. P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614.
8. Chenoweth, D. E., and T. E. Hugli. 1978. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 75: 3943.
9. Burg, M., U. Martin, C. Rheinheimer, J. Kohl, W. Bautsch, E. C. Bottger, and A. Klos. 1995. IFN-γ up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J. Immunol. 155:4419.
10. Gasque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Gotze, and B. P. Morgan. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882.
11. Haviland, D. L., R. L. McCoy, W. T. Whitehead, H. Akama, E. P. Molmenti, A. Brown, J. C. Haviland, W. C. Parks, and D. H. Perlmutter 1995. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154:1861.
12. Buchner, R. R., T. E. Hugh, J. A. Ember, and E. L. Morgan. 1995. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. J. Immunol. 155:308.
13. Shibata, T., F. G. Cosio, and D. J. Birmingham. 1991. Complement activation induces the expression of decay accelerating factor on human mesangial cells. J. Immunol. 147:3901.
14. Cosio, F. G., T. Shibata, B. H. Rovin, and D. J. Birmingham. 1994. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int. 46:986.
15. Hebert, L. A., and F. G. Cosio. 1992. The role of the complement system in renal injury. Semin. Nephrol. 12:408.
16. Camey, D. F., T. J. Lang, and M. L. Shin. 1990. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145:623.
17. Lovett, D. H., G. M. Mansch, M. Goppelt, K. Resch, and D. Gemsa. 1987. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J. Immunol. 138:2473.
18. Cybulsky, A. V. 1991. Release of arachidonic acid by complement C5b-9 complex in glomerular epithelial cells. Am. J. Physiol. 261:F427.
19. Ross, G. D., and M. E. Medof. 1985. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol. 37:217.
20. Fisher, E., M. D. Appay, and M. D. Kazatchkine. 1984. The human glomerular C3 receptor. Mol. Immunol. 21:1223.
21. Van den Dobbelsteen, M. E. A., F. J. van der Woude. W. E. M. Schroeijers, N. Klar-Mohamad, L. A. van Es, and M. R. Daha. 1996. Bolh IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J. Am. Soc. Nephrol 7:573.
22. Marceau, F., D. deBlois, C. Laplante, E. Petitclerc, G. Pelletier, J. H. Grose, and T. E. Hugli. 1990. Contractile effect of the chemotactic factors f-met-Leu-Phe and C5a on the human isolated umbilical artery: role of cyclooxygenase products and tissue macrophages. Circ. Res. 67:1059.
23. Morgan, E. L., J. A. Ember, S. D. Sanderson, W. Scholz, R. Buchner, R. D. Ye, and T. E. Hugli. 1993. Anti-C5a receptor antibodies: characterization of neutralizing antibodies specific for a peptide, C5aR(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J. Immunol. 151:377.
24. Kaumaya, P. T. P., A. M. VanBuskirk, E. Goldberg, and S. K. Pierce. 1992. Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines. J. Biol. Chem. 267:6338.
25. 2-terminal domain. J. Immunol 151:3785.
26. Kaumaya, P. T. P., S. Kobs-Conrad, A. M. DiGeorge, and V. C. Stevens. 1994. "De novo" engineering of peptide immunogenic and antigenic determinants as potential vaccines. In Peptides: Design, Synthesis, and Biological Activity. C. Basava and G. M. Anantharamaiah, eds. Birkhauser, Boston, p. 133.
27. Kaumaya, P. T. P., S. Kobs-Conrad, V. Hoon Seo, H. Lee, A. M. VanBuskirk, N. Feng, J. F. Sheridan, and V. Stevens. 1993. Peptide vaccines incorporating a ''promiscuous" T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J. Mol. Recognit. 6:81.
28. Cosio, F. G., X. Shen, D. J. Birmingham, M. E. van Aman, and L. A. Hebert. 1990. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:4198.
29. Okubo, S., F. Niimura, H. Nishimura, F. Tkemoto, A. Fogo, T. Matsusaka, and I. Ichikawa. 1997. Angiotensin-independent mechanism of aldosterone synthesis during chronic extracellular fluid volume depletion. J. Clin. Invest. 99:855.
30. Richard, S., C. A. Farrell, A. S. Shaw, H. J. Showell, and P. A. Connelly. 1994. C5a as a model for chemotactic factor-stimulated tyrosine phosphoryiation in the human neutrophil. J. Immunol. 152:2479.
31. Chomczysnski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
32. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
33. Osborn, L., S. Kunkel, and G. Nabel. 1989. Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86:2336.
34. Cosio, F. G., and W. A. Wilmer. 1995. Effects of high glucose concentration on c-fos: role of protein kinase C. Kidney Int. 51:S-3.
35. Boulay, F., L. Mery, M. Tardif, L. Brouchon, and P. Vignais. 1991. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30:2993.
36. Watanabe, H., M. Kuraya, R. Kasukawa, H. Yanagisawa, M. Yanagisawa, and T. Fujita. 1995. Analysis of C5a receptor by monoclonal antibody. J. Immunol. Methods 185:19.
37. Cosio, F. G., D. D. Sedmak, J. D. Mahan, and N. S. Nahman, Jr. 1989. Localization of decay-accelerating factor in normal and diseased kidneys. Kidney Int. 36:100.
38. Shibata, T., and T. Kohsaka. 1995. Effects of complement activation on the expression of CD59 by human mesangial cells. J. Immunol. 155:403.
39. Quigg, R. J., B. P. Morgan, V. M. Hollers, S. Adler, A. E. I. Sneed, and C. F. Lo. 1995. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int. 48:412.
40. Nangaku, M., R. L. Meek, J. Pippin, K. L. Gordon, B. P. Morgan, R. J. Johnson, and W. G. Couser. 1996. Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int. 50:257.
41. Holers, V. M., J. L. Cole, D. M. Lublin, T. Seya, and J. P. Atkinson. 1989. Human C3b and C4b regulatory proteins: a new multi-gene family. Immunol. Today 6:188.
42. Mene, P., M. S. Simonson, and M. J. Dunn. 1989. Physiology of the mesangial cell. Physiol. Rev. 69:1347.
43. Kreisberg, J. I., M. Venkatachalam, and D. Troyer. 1985. Contractile properties of cultured glomerular mesangial cells. Am. J. Physiol. 249:F457.
44. Schlondorff, D. O. 1987. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1:272.
45. Pelayo, J. C. D. E. Chenoweth, and T. E. Hugli. 1986. Effects of the anaphylatoxin C5a on renal and glomerular hemodynamics in the rat. Kidney Int. 30:62.
46. Sekse, I., B. M. Iversen, M. R. Daha, and J. Ofstad. 1992. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the alpha-adrenergic nervous system. Nephron 60:453.
47. Cosio, F. G., J. T. Innes, N. S. Nahman, Jr., J. D. Mahan, and R. M. Ferguson. 1987. Cyclosporine potentiates the nephrotoxic effects of endotoxin. Transplantation 44:425.
48. Goodman, M. G., D. E. Chenoweth, and W. O. Weigle. 1982. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface receptors. J. Exp. Med. 1156:912.